Works matching IS 00070920 AND DT 2012 AND VI 106 AND IP 10

Results: 22

Incidence and possible pathogenesis of sentinel node micrometastases in ductal carcinoma in situ of the breast detected using molecular whole lymph node assay.

Published in:

2012

By:

Osako T;
Iwase T;
Kimura K;
Masumura K;
Horii R;
Akiyama F;
Osako, T;
Iwase, T;
Kimura, K;
Masumura, K;
Horii, R;
Akiyama, F

Publication type:

journal article

PPARγ agonists regulate the expression of stemness and differentiation genes in brain tumour stem cells.

Published in:

2012

By:

Pestereva E;
Kanakasabai S;
Bright JJ;
Pestereva, E;
Kanakasabai, S;
Bright, J J

Publication type:

journal article

Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-α.

Published in:

2012

By:

Patil S;
Figlin RA;
Hutson TE;
Michaelson MD;
Negrier S;
Kim ST;
Huang X;
Motzer RJ;
Patil, S;
Figlin, R A;
Hutson, T E;
Michaelson, M D;
Negrier, S;
Kim, S T;
Huang, X;
Motzer, R J

Publication type:

journal article

Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome.

Published in:

2012

By:

Krakstad C;
Trovik J;
Wik E;
Engelsen IB;
Werner HM;
Birkeland E;
Raeder MB;
øyan AM;
Stefansson IM;
Kalland KH;
Akslen LA;
Salvesen HB;
Krakstad, C;
Trovik, J;
Wik, E;
Engelsen, I B;
Werner, H M J;
Birkeland, E;
Raeder, M B;
Øyan, A M

Publication type:

journal article

The dynamic change of circulating tumour cells in patients with operable breast cancer before and after chemotherapy based on a multimarker QPCR platform.

Published in:

British Journal of Cancer, 2012, v. 106, n. 10, p. 1605, doi. 10.1038/bjc.2012.157

By:

Chong, M-h;
Zhao, Y;
Wang, J;
Zha, X-m;
Liu, X-a;
Ling, L-j;
Du, Q;
Wang, S

Publication type:

Article

Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome.

Published in:

British Journal of Cancer, 2012, v. 106, n. 10, p. 1682, doi. 10.1038/bjc.2012.91

By:

Krakstad, C;
Trovik, J;
Wik, E;
Engelsen, I B;
Werner, H M J;
Birkeland, E;
Raeder, M B;
Øyan, A M;
Stefansson, I M;
Kalland, K H;
Akslen, L A;
Salvesen, H B

Publication type:

Article

Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysis of randomised controlled trials.

Published in:

British Journal of Cancer, 2012, v. 106, n. 10, p. 1626, doi. 10.1038/bjc.2012.147

By:

Ethier, M C;
Science, M;
Beyene, J;
Briel, M;
Lehrnbecher, T;
Sung, L

Publication type:

Article

Germline BRCA1 mutations increase prostate cancer risk.

Published in:

British Journal of Cancer, 2012, v. 106, n. 10, p. 1697, doi. 10.1038/bjc.2012.146

By:

Leongamornlert, D;
Mahmud, N;
Tymrakiewicz, M;
Saunders, E;
Dadaev, T;
Castro, E;
Goh, C;
Govindasami, K;
Guy, M;
O'Brien, L;
Sawyer, E;
Hall, A;
Wilkinson, R;
Easton, D;
Goldgar, D;
Eeles, R;
Kote-Jarai, Z

Publication type:

Article

Incidence and possible pathogenesis of sentinel node micrometastases in ductal carcinoma in situ of the breast detected using molecular whole lymph node assay.

Published in:

British Journal of Cancer, 2012, v. 106, n. 10, p. 1675, doi. 10.1038/bjc.2012.168

By:

Osako, T;
Iwase, T;
Kimura, K;
Masumura, K;
Horii, R;
Akiyama, F

Publication type:

Article

Expression of Forkhead box P3 in tumour cells causes immunoregulatory function of signet ring cell carcinoma of the stomach.

Published in:

British Journal of Cancer, 2012, v. 106, n. 10, p. 1668, doi. 10.1038/bjc.2012.141

By:

Yoshii, M;
Tanaka, H;
Ohira, M;
Muguruma, K;
Iwauchi, T;
Lee, T;
Sakurai, K;
Kubo, N;
Yashiro, M;
Sawada, T;
Hirakawa, K

Publication type:

Article

Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 10, p. 1591, doi. 10.1038/bjc.2012.143

By:

Jo, J-C;
Lee, J-L;
Ryu, M-H;
Chang, H M;
Kim, M;
Lee, H J;
Kim, H-S;
Shin, J-G;
Kim, T-W;
Kang, Y-K

Publication type:

Article

A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours.

Published in:

British Journal of Cancer, 2012, v. 106, n. 10, p. 1598, doi. 10.1038/bjc.2012.154

By:

Boss, D S;
Glen, H;
Beijnen, J H;
Keesen, M;
Morrison, R;
Tait, B;
Copalu, W;
Mazur, A;
Wanders, J;
O'Brien, J P;
Schellens, J H M;
Evans, T R J

Publication type:

Article

The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function.

Published in:

British Journal of Cancer, 2012, v. 106, n. 10, p. 1638, doi. 10.1038/bjc.2012.131

By:

Baker, L C J;
Boult, J K R;
Walker-Samuel, S;
Chung, Y-L;
Jamin, Y;
Ashcroft, M;
Robinson, S P

Publication type:

Article

Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cells.

Published in:

British Journal of Cancer, 2012, v. 106, n. 10, p. 1648, doi. 10.1038/bjc.2012.129

By:

Troiani, T;
Vecchione, L;
Martinelli, E;
Capasso, A;
Costantino, S;
Ciuffreda, L P;
Morgillo, F;
Vitagliano, D;
D'Aiuto, E;
De Palma, R;
Tejpar, S;
Van Cutsem, E;
De Lorenzi, M;
Caraglia, M;
Berrino, L;
Ciardiello, F

Publication type:

Article

The differential effects of statins on the metastatic behaviour of prostate cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 10, p. 1689, doi. 10.1038/bjc.2012.138

By:

Brown, M;
Hart, C;
Tawadros, T;
Ramani, V;
Sangar, V;
Lau, M;
Clarke, N

Publication type:

Article

The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS.

Published in:

British Journal of Cancer, 2012, v. 106, n. 10, p. 1611, doi. 10.1038/bjc.2012.151

By:

Wallis, M G;
Clements, K;
Kearins, O;
Ball, G;
Macartney, J;
Lawrence, G M

Publication type:

Article

Towards individualisation of treatment in endometrial cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 10, p. 1581, doi. 10.1038/bjc.2012.140

By:

Taylor, S E;
Green, J A

Publication type:

Article

Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma.

Published in:

British Journal of Cancer, 2012, v. 106, n. 10, p. 1583, doi. 10.1038/bjc.2012.144

By:

Prado, C M M;
Bekaii-Saab, T;
Doyle, L A;
Shrestha, S;
Ghosh, S;
Baracos, V E;
Sawyer, M B

Publication type:

Article

Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 10, p. 1618, doi. 10.1038/bjc.2012.156

By:

Ribi, K;
Aldridge, J;
Phillips, K-A;
Thompson, A;
Harvey, V;
Thürlimann, B;
Cardoso, F;
Pagani, O;
Coates, A S;
Goldhirsch, A;
Price, K N;
Gelber, R D;
Bernhard, J

Publication type:

Article

PPARγ agonists regulate the expression of stemness and differentiation genes in brain tumour stem cells.

Published in:

British Journal of Cancer, 2012, v. 106, n. 10, p. 1702, doi. 10.1038/bjc.2012.161

By:

Pestereva, E;
Kanakasabai, S;
Bright, J J

Publication type:

Article

Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-α.

Published in:

British Journal of Cancer, 2012, v. 106, n. 10, p. 1587, doi. 10.1038/bjc.2012.149

By:

Patil, S;
Figlin, R A;
Hutson, T E;
Michaelson, M D;
Negrier, S;
Kim, S T;
Huang, X;
Motzer, R J

Publication type:

Article

The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction.

Published in:

British Journal of Cancer, 2012, v. 106, n. 10, p. 1660, doi. 10.1038/bjc.2012.139

By:

Descamps, G;
Gomez-Bougie, P;
Tamburini, J;
Green, A;
Bouscary, D;
Maïga, S;
Moreau, P;
Le Gouill, S;
Pellat-Deceunynck, C;
Amiot, M

Publication type:

Article